Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999

Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999–2010

Published:2014-07 Issue:7 Volume:24 Page:516-521.e1
ISSN:1047-2797
Container-title:Annals of Epidemiology
language:en
Short-container-title:Annals of Epidemiology

Author:

Wong Hoi Kin,Ong Kwok Leung,Cheung Ching-Lung,Cheung Bernard M.Y.

Publisher

Elsevier BV

Subject

Epidemiology

Reference30 articles.

1. The Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States; 2011.

2. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006;Cheung;Am J Med,2009

3. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008

4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38;BMJ,1998

5. Diabetic nephropathy: diagnosis, prevention, and treatment;Gross;Diabetes Care,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study;BMC Public Health;2021-06-21

2. Differences in U.S. Rural-Urban Trends in Diabetes ABCS, 1999–2018;Diabetes Care;2021-06-14

3. Type 2 diabetes mellitus and osteoarthritis;Seminars in Arthritis and Rheumatism;2019-08

4. The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes;Endocrinology and Metabolism;2019

5. Changing predictors of statin initiation in US women over two decades;Pharmacoepidemiology and Drug Safety;2018-12-19